Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics.
about
Recent advances in prenatal genetic screening and testingMaking genomic medicine evidence-based and patient-centered: a structured review and landscape analysis of comparative effectiveness researchPopulation-based impact of noninvasive prenatal screening on screening and diagnostic testing for fetal aneuploidy.Sociodemographic and attitudinal predictors of simultaneous and redundant multiple marker and cell-free DNA screening among women aged ⩾35 years.Benefits and limitations of prenatal screening for Prader-Willi syndrome.The clinical utility of genome-wide non invasive prenatal screening.Non-invasive prenatal screening versus prenatal diagnosis by array comparative genomic hybridization: a comparative retrospective study.Noninvasive prenatal screening for fetal common sex chromosome aneuploidies from maternal blood.Noninvasive prenatal screening at low fetal fraction: comparing whole-genome sequencing and single-nucleotide polymorphism methods.Should we 'open the kimono' to release the results of rare autosomal aneuploidies following noninvasive prenatal whole genome sequencing?Genome-wide cfDNA screening: clinical laboratory experience with the first 10,000 cases.QUAD versus cfDNA in an urban population in the second trimester for detection of trisomy 21: a cost sensitivity analysis.Recommended practice for laboratory reporting of non-invasive prenatal testing of trisomies 13, 18 and 21: a consensus opinion.False negative fetal cell free DNA screening for microdeletion syndromes in the presence of an unbalanced translocation involving monosomy 4p.Diagnostic cytogenetic testing following positive noninvasive prenatal screening results: a clinical laboratory practice resource of the American College of Medical Genetics and Genomics (ACMG).Clinical experience with a single-nucleotide polymorphism-based non-invasive prenatal test for five clinically significant microdeletions.Noninvasive prenatal diagnosis of fetal aneuploidy by circulating fetal nucleated red blood cells and extravillous trophoblasts using silicon-based nanostructured microfluidics.The clinical utility of DNA-based screening for fetal aneuploidy by primary obstetrical care providers in the general pregnancy population.Prenatal Screening for 22q11.2 Deletion Using a Targeted Microarray-Based Cell-Free DNA Test.Medical genetics and genomic medicine in the United States. Part 2: Reproductive genetics, newborn screening, genetic counseling, training, and registries.Cherchez la femme: maternal incidental findings can explain discordant prenatal cell-free DNA sequencing results.Informative priors on fetal fraction increase power of the noninvasive prenatal screen.Prenatal reflex DNA screening for trisomies 21, 18, and 13.Offering non-invasive prenatal testing as part of routine clinical service. Can high levels of informed choice be maintained?Parental decisions following prenatal diagnosis of sex chromosome aneuploidy in Hong Kong.Non-invasive prenatal testing (NIPT): Europe's first multicenter post-market clinical follow-up study validating the quality in clinical routine.Implementing Group Prenatal Counseling for Expanded Noninvasive Screening Options.Comparison of first-tier cell-free DNA screening for common aneuploidies with conventional publically funded screening.Comment on "The clinical utility of genome-wide non invasive prenatal screening".Response to "Noninvasive prenatal screening at low fetal fraction: comparing whole-genome sequencing and single-nucleotide polymorphism methods".Clinical accuracy of abnormal cell-free fetal DNA results for the sex chromosomes.Contribution of maternal copy number variations to false-positive fetal trisomies detected by noninvasive prenatal testing.Diagnostic performance and costs of contingent screening models for trisomy 21 incorporating non-invasive prenatal testing.What do the new American College of Medical Genetics and Genomics (ACMG) guidelines mean for the provision of non-invasive prenatal genetic screening?Maternal Malignancy Evaluation After Discordant Cell-Free DNA Results.Prenatal diagnosis by chromosomal microarray analysis.Screening for fetal chromosomal and subchromosomal disorders.Origin and clinical relevance of chromosomal aberrations other than the common trisomies detected by genome-wide NIPS: results of the TRIDENT study.Obstetrical provider knowledge and attitudes towards cell-free DNA screening: results of a cross-sectional national survey.A quantitative cSMART assay for noninvasive prenatal screening of autosomal recessive nonsyndromic hearing loss caused by GJB2 and SLC26A4 mutations.
P2860
Q28071888-250181D7-C592-4028-AF0A-FB886481A490Q38730837-2FC2570B-F039-4870-99AC-3FCF488134DDQ38778126-8B0C6D7C-85F5-4A8B-A37A-4166948B325BQ38792902-B1E98ACF-984F-4D1C-9E5D-4E5C5CABE607Q38830153-9CAC4C5E-F611-4554-9A5A-309467EBF68EQ38830275-5BB6E633-06ED-4086-AB07-EE56675F5C43Q38838610-3CA3C782-6E97-4C2A-8067-F1B1B6DCDA26Q38867682-AA1AD86C-90E6-43DF-A92B-A9FED801FF64Q38895114-6CBA27FD-4664-4B13-AAC7-20F077BE241BQ39068479-B81B04F1-8D47-4572-BB5F-70D2B864283AQ39375461-49B40D9A-9969-4A7C-85FD-2B01E74F9F16Q40413919-0DDC5C13-09BA-4C8C-8168-C63E38BF83AFQ41113357-BA0D5645-B092-445A-B5DD-4CA99D1DDA35Q45965934-95F54BB8-F625-431F-BAF9-6B9CC679A470Q46058669-034184D4-1B6D-40FD-90D2-EDEB1DBD38EFQ46081566-51113CB2-495B-48A0-A126-29104D6F5922Q46181819-342BF9B2-2E7C-488F-96A9-ACEDA0D2D050Q46271940-9463A4C9-A9D4-487B-98E4-BD96F012A527Q46480890-F582229E-4EFC-409A-ABFC-8B82175D6244Q47140110-3BE75CEE-6098-4C4E-B032-3BAF20B07E87Q47351507-BE4B2E05-1BFA-45CE-AB88-21830615B548Q47366013-9912CCCC-D8D9-4530-ACFA-EF90896DC248Q47421797-61715812-2185-4B2C-A1F6-7F7E552C6363Q48094333-D1B3FF25-8857-45CA-A0F0-EB9EAB2074D1Q48094362-773A8729-4BD0-4722-BC6B-847D927D5B02Q48100099-8B742292-60A6-4911-999D-16EA8E2C6DF4Q48106979-16E0B0AF-E487-4E9C-BFE8-CB7CC1791E22Q48110029-DEB888D9-89FC-4893-8903-3E2FBEF2D7BFQ48150112-93D70523-6781-4E34-BE89-44A332CCFCC6Q48180522-808ABDA5-95ED-4FDB-89F6-6E98C9A1711EQ48181767-F9E56294-BF54-4F53-AA13-9ADEF7478423Q48282895-818D96C4-BBF4-47B3-AD41-8BED711A553BQ48335557-1BED3CBF-2797-4266-8132-7A063A52E3BFQ48338877-9C86855A-C4E4-45F0-8F96-C211FB8148F2Q48506249-920F72A4-2663-4B8D-A5CD-574A90F9A3E9Q49973199-DE2D5E25-EA1F-4A56-B264-4A211179E875Q50058086-95D7240E-EB07-4938-A733-C00B19EFA06DQ50093623-C481F604-AC5F-46ED-A6BD-B3CACA7F8BB6Q50191785-2870A14A-60D4-4AEC-A8A4-0D42E795727EQ50346367-D1F1BC7F-13E7-4269-B4B7-2193CDBB8531
P2860
Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics.
description
2016 nî lūn-bûn
@nan
2016 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Noninvasive prenatal screening ...... Medical Genetics and Genomics.
@ast
Noninvasive prenatal screening ...... Medical Genetics and Genomics.
@en
Noninvasive prenatal screening ...... Medical Genetics and Genomics.
@nl
type
label
Noninvasive prenatal screening ...... Medical Genetics and Genomics.
@ast
Noninvasive prenatal screening ...... Medical Genetics and Genomics.
@en
Noninvasive prenatal screening ...... Medical Genetics and Genomics.
@nl
prefLabel
Noninvasive prenatal screening ...... Medical Genetics and Genomics.
@ast
Noninvasive prenatal screening ...... Medical Genetics and Genomics.
@en
Noninvasive prenatal screening ...... Medical Genetics and Genomics.
@nl
P2093
P2860
P356
P1433
P1476
Noninvasive prenatal screening ...... Medical Genetics and Genomics.
@en
P2093
Anthony R Gregg
Brian G Skotko
Judith L Benkendorf
Kristin G Monaghan
Michael S Watson
Robert G Best
Susan Klugman
P2860
P2888
P304
P356
10.1038/GIM.2016.97
P407
P50
P577
2016-07-28T00:00:00Z